Comment on CMS-2026-2080-0001
Michelle HuangSupportIndividual
Summary: The commenter supports the Medicare Drug Price Negotiation Program, arguing that it will improve medication affordability and patient health outcomes. They specifically encourage CMS to prioritize access to affordable drugs for chronic conditions while maintaining transparency in the negotiation process.
I support the Medicare Drug Price Negotiation Program because it has the potential to improve medication affordability and adherence among Medicare beneficiaries. High prescription drug costs can prevent patients from obtaining the necessary treatments, leading to poorer health outcomes and increased rates of unnecessary hospitalizations and healthcare expenditures.
I encourage CMS to continue prioritizing access to affordable prescriptions for patients with chronic conditions such as type 2 diabetes, cardiovascular disease, and even heart failure while ensuring transparency of the negotiation process. By lowering drug costs, Medicare beneficiaries may experience a reduced financial burden, enhanced medication adherence, improved disease management, and ameliorated health conditions.